TrialOpen forum infectious diseases2024

A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019.

Alyson Haslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.